There has been a distinct shift in the scope and breadth of investigations by global competition regulators, as well as an uptick in the number of antitrust related litigations. With an administration change in the US and political shifts in other jurisdictions, the increased focus on regulatory enforcement of competition and antitrust laws, rapidly changing policies, and the growing collaboration of regulatory agencies, the rise of collective actions or mass competition claims is expected to continue throughout 2021. Not only are enforcement agencies considering the business and economic impact of mergers, recent developments suggest they are also assessing the role of competition law in advancing goals relating to labor, environmental and sustainability agreements, and other social and governance issues.read more
In 2020, like most other industries, the energy sector faced extreme challenges stemming from the pandemic. People were relying less on energy due to workforce and lifestyle changes. Last year also brought market dislocations when the global demand for oil disappeared and the price for a barrel of oil shrank to unprecedented low levels.read more
For years, the number of people becoming addicted to opioid-based pharmaceuticals has rapidly increased. People who are chronic users of opioid drugs can experience severe side effects and are at a greater risk of overdose related death. The Centers for Disease Control and Prevention estimates that opioids account for 68% all drug overdose deaths, and in 2017, the U.S. Department of Health and Human Services declared a public health emergency for America’s opioid epidemic. Several states, individuals, and other government divisions have filed lawsuits against various entities involved in the creation and sale of prescription, opioid-based painkillers.